QOLP-23. PHASE II RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF ACETAZOLAMIDE VERSUS PLACEBO FOR CEREBRAL OEDEMA IN RECURRENT AND/OR PROGRESSIVE HIGH-GRADE GLIOMA REQUIRING TREATMENT WITH DEXAMETHASONE
Meera Agar(University of Technology Sydney), Eng‐Siew Koh(Liverpool Hospital), Anna K. Nowak(The University of Western Australia), Robyn Leonard(The University of Sydney), Rosemary Harrup(University of Tasmania), Elizabeth H Barnes, Ganessan Kichenadasse(Flinders University), Hao‐Wen Sim(The University of Sydney), Janette L. Vardy(The University of Sydney), Elizabeth Hovey, Cecelia Gzell(Australian and New Zealand Intensive Care Society), Anthony Dowling(Monash University), Helen Wheeler(The University of Sydney), Tracey Dunlop(St George Hospital), Desma Spyridopoulos(The University of Sydney), Merryn Hall(Cooperative Trials Group for Neuro-Oncology), Zarnie Lwin(The University of Queensland), Ross Jennens, John Simes(The University of Sydney), Evonne Tim(The University of Sydney)
Cited by 0
Related Papers
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
|The Lancet|2019|785
Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors (GIST): A meta-analyis based on 1,640 patients (pts)
|Journal of Clinical Oncology|2007|383
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|Blood|2019|369
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
|The Lancet Diabetes & Endocrinology|2016|338